Sarpogrelate (, ), sold under the brand names Anplag and Sapodifil, is a serotonin 5-HT2 receptor antagonist which is used in the treatment of arterial occlusive disorders such as peripheral artery disease in Japan, South Korea, and China. Development in the United States and the European Union was discontinued and it is not available in these regions.
{{Drugbox | Verifiedfields = verified | verifiedrevid = 407721136 | image = Sarpogrelate structure.svg | image_class = skin-invert-image | width = 250px
| tradename = Anplag; Sapodifil | Drugs.com = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | routes_of_administration = | class = Serotonin 5-HT2 receptor antagonist; Serotonin 5-HT2A receptor antagonist; Anticoagulant; Platelet aggregation inhibitor | ATC_prefix = None | ATC_suffix =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).